MedTrace Logo

Sulodexide Efficacy in Chronic Idiopathic Subjective Tinnitus

NCT02737670 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 126

Last updated 2017-09-14

No results posted yet for this study

Summary

The objective of this prospective randomized and double blind controlled study is to evaluate the efficacy and safety of Sulodexide (25 mg) in the treatment of chronic idiopathic subjective tinnitus.

Conditions

  • Tinnitus, Subjective

Interventions

DRUG

Sulodexide

25 mg morning and evening for 40 days

DRUG

Placebo

1 tablet morning and evening for 40 days

Sponsors & Collaborators

  • St Joseph University, Beirut, Lebanon

    lead OTHER

Principal Investigators

  • Elias Eter, MD · Faculty of Medicine - St Joseph University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-08-31
Primary Completion
2017-03-31
Completion
2017-08-31

Countries

  • Lebanon

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02737670 on ClinicalTrials.gov